載入...
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
BACKGROUND: Rifaximin and lactulose are common effective agents for hepatic encephalopathy (HE). Whether a combination of rifaximin and lactulose improves the efficacy and mortality in patients with HE compared with lactulose alone needs to be analyzed. METHODS: A systematic search was performed in...
Na minha lista:
| 發表在: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301297/ https://ncbi.nlm.nih.gov/pubmed/30587923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S172324 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|